Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
May 25 2023 - 8:56AM
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical
robotics for minimally invasive endovascular intervention, today
announced that David Fischel, Chairman and CEO, will participate in
Craig-Hallum’s 20th Annual Institutional Investor Conference.
Mr. Fischel will be available on Wednesday, May
31, 2023 for one-on-one meetings with conference attendees.
“We appreciate the invitation by Craig-Hallum
and look forward to sharing Stereotaxis’ differentiated technology,
clinical value, and growth strategy with investors,” says Mr.
Fischel.
About StereotaxisStereotaxis
(NYSE: STXS) is a pioneer and global leader in innovative surgical
robotics for minimally invasive endovascular intervention. Its
mission is the discovery, development and delivery of robotic
systems, instruments, and information solutions for the
interventional laboratory. These innovations help physicians
provide unsurpassed patient care with robotic precision and safety,
expand access to minimally invasive therapy, and enhance the
productivity, connectivity, and intelligence in the operating room.
Stereotaxis technology has been used to treat over 100,000 patients
across the United States, Europe, Asia, and elsewhere. For more
information, please visit www.stereotaxis.com
Stereotaxis Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
314-678-6100
investors@stereotaxis.com
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From Sep 2023 to Sep 2024